CompaniesBlu Pharmaceuticals

Blu Pharmaceuticals

defunct

About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (2)

Total Trials

2

As Lead Sponsor

1

As Collaborator

1

Total Enrollment

126

By Phase

NA: 2

By Status

COMPLETED: 2

Clinical Trials Pipeline2 trials

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2020

2021

2022

2023

2024

Today

Hover over trial bars to see details

Recent Trials

NCT04529473Collaborator

Efficacy and Safety of 12-weeks Supplementation of Eubacterium Hallii on Insulin Sensitivity and Glycaemic Control

100 participants

Started: Feb 3, 2021 · Completed: Aug 23, 2022

NCT04495972Lead Sponsor

Intestinimonas for Prevention of Type 2 Diabetes Mellitus

26 participants

Started: Jan 15, 2021 · Completed: Nov 10, 2023

Related Companies

Puracap

acquired

Blu Pharmaceuticals | Biotech Hunter | Biotech Hunter